FDA, CRN Say Proper Supplement Labeling Can Enhance Consumer Trust
This article was originally published in The Tan Sheet
Executive Summary
The current implementation of health claims and labeling information for foods and supplements is not adequately informing consumers on how to make healthy dietary choices, according to CFSAN's Barbara Schneeman, PhD
You may also be interested in...
XanGo Brochures Draw FDA Warning Letter For Unsubstantiated Claims
An FDA Warning Letter citing unapproved new drug claims for XanGo Mangosteen juice that XanGo said were made by a third party underscores the agency's position on the responsibility supplement manufacturers assume for unsubstantiated label statements
XanGo Brochures Draw FDA Warning Letter For Unsubstantiated Claims
An FDA Warning Letter citing unapproved new drug claims for XanGo Mangosteen juice that XanGo said were made by a third party underscores the agency's position on the responsibility supplement manufacturers assume for unsubstantiated label statements
XanGo Brochures Draw FDA Warning Letter For Unsubstantiated Claims
An FDA Warning Letter citing unapproved new drug claims for XanGo Mangosteen juice that XanGo said were made by a third party underscores the agency's position on the responsibility supplement manufacturers assume for unsubstantiated label statements